Bruno P. Moreira

Bruno P. Moreira

Auto-generated profile, based on publicly available information

Bruno P. Moreira

Department of Microscopy, Laboratory of Cell Biology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, P.O. Box 4050-313, Porto,Portugal

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BMBruno P. Moreira
Bruno P. Moreira
Pedro F. OliveiraPedro F. Oliveira
Pedro F. Oliveira
Marco AlvesMarco Alves
Marco Alves
In recent years, the mammalian target of rapamycin (mTOR) has emerged as a master integrator of upstream inputs, such as amino acids, growth factors and insulin availability, energy status and many others. The integration of these signals promotes a response through several downstream effectors that regulate protein synthesis, glucose metabolism and cytoskeleton organization, among others. All these biological processes are essential for male fertility, thus it is not surprising that novel molecular mechanisms controlled by mTOR in the male reproductive tract have been described. Indeed, since the first clinical evidence showed that men taking rapamycin were infertile, several studies have evidenced distinct roles for mTOR in spermatogenesis. However, there is a lack of consensus whether mTOR inhibition, which remains the experimental approach that originates the majority of available data, has a negative or positive impact on male reproductive health. Herein we discuss the latest findings concerning mTOR activity in testes, particularly its role on spermatogonial stem cell (SSC) maintenance and differentiation, as well as in the physiology of Sertoli cells (SCs), responsible for blood–testis barrier maintenance/restructuring and the nutritional support of spermatogenesis. Taken together, these recent advances highlight a crucial role for mTOR in determining the male reproductive potential.

6 February 2019 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
RBRaquel L. Bernardino
Raquel L. Bernardino
TDTânia Dias
Tânia Dias
BMBruno P. Moreira
Bruno P. Moreira
MCMariana Cunha
Mariana Cunha
ABAlberto Barros
Alberto Barros
Pedro F. OliveiraPedro F. Oliveira
Pedro F. Oliveira
The process that allows cells to control their pH and bicarbonate levels is essential for ionic and metabolic equilibrium. Carbonic anhydrases (CAs) catalyse the conversion of CO2 to and H+ and are thus essential for this process. Herein, we inhibited CAs with acetazolamide – ACT and SLC‐0111 – to study their involvement in the metabolism, mitochondrial potential, mitochondrial biogenesis and lipid metabolism of human Sertoli cells (hSCs), obtained from biopsies from men with conserved spermatogenesis. We were able to identify three isoforms of CAs, one mitochondrial isoform (CA VB) and two cell membrane‐bound isoforms (CA IX and CA XII) in hSCs. When assessing the expression of markers for mitochondrial biogenesis, we observed a decrease in HIF‐1α, SIRT1, PGC1α and NRF‐1 mRNAs after all CAs were inhibited, resulting in decreased mitochondrial DNA copy numbers. This was followed by an increased production of lactate and alanine in the same conditions. In addition, consumption of glucose was maintained after inhibition of all CAs in hSCs. These results indicate a reduced conversion of pyruvate to acetyl‐coA, possibly due to decreased mitochondrial function, caused by CA inhibition in hSCs. Inhibition of CAs also caused alterations in lipid metabolism, since we detected an increased expression of hormone‐sensitive lipase (HSL) in hSCs. Our results suggest that CAs are essential for mitochondrial biogenesis, glucose and lipid metabolism in hSCs. This is the first report showing that CAs play an essential role in hSC metabolic dynamics, being involved in mitochondrial biogenesis and controlling lactate production.

23 December 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SPSara Catarina Pereira
Sara Catarina Pereira
Ana D MartinsAna D Martins
Ana D Martins
BMBruno P. Moreira
Bruno P. Moreira
RBRaquel L. Bernardino
Raquel L. Bernardino
ABAlberto Barros
Alberto Barros
Marco AlvesMarco Alves
Marco Alves

20 November 2018 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
BMBruno P. Moreira
Bruno P. Moreira
MMMariana Monteiro
Mariana Monteiro
MSMário Sousa
Mário Sousa
Pedro F. OliveiraPedro F. Oliveira
Pedro F. Oliveira
Marco AlvesMarco Alves
Marco Alves
Obesity stands as one of the greatest healthcare challenges of the 21st century. Obesity in reproductive-age men is ever more frequent and is reaching upsetting levels. At the same time, fertility has taken an inverse direction and is decreasing, leading to an increased demand for fertility treatments. In half of infertile couples, there is a male factor alone or combined with a female factor. Furthermore, male fertility parameters such as sperm count and concentration went on a downward spiral during the last few decades and are now approaching the minimum levels established to achieve successful fertilization. Hence, the hypothesis that obesity and deleterious effects in male reproductive health, as reflected in deterioration of sperm parameters, are somehow related is tempting. Most often, overweight and obese individuals present leptin levels directly proportional to the increased fat mass. Leptin, besides the well-described central hypothalamic effects, also acts in several peripheral organs, including the testes, thus highlighting a possible regulatory role in male reproductive function. In the last years, research focusing on leptin effects in male reproductive function has unveiled additional roles and molecular mechanisms of action for this hormone at the testicular level. Herein, we summarize the novel molecular signals linking metabolism and male reproductive function with a focus on leptin signaling, mitochondria and relevant pathways for the nutritional support of spermatogenesis.

1 March 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
BMBruno P. Moreira
Bruno P. Moreira
JSJuliana F. Silva
Juliana F. Silva
Ivana JarakIvana Jarak
Ivana Jarak
Maria de Lourdes PereiraMaria de Lourdes Pereira
Maria de Lourdes Pereira
Pedro F. OliveiraPedro F. Oliveira
Pedro F. Oliveira
Marco AlvesMarco Alves
Marco Alves

1 March 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
JSJuliana F. Silva
Juliana F. Silva
BMBruno P. Moreira
Bruno P. Moreira
LRLuís Rato
Luís Rato
Maria de Lourdes PereiraMaria de Lourdes Pereira
Maria de Lourdes Pereira
Pedro F. OliveiraPedro F. Oliveira
Pedro F. Oliveira
Marco AlvesMarco Alves
Marco Alves
The prevalence of obesity has tripled in recent decades and is now considered an alarming public health problem. In recent years, a group of endocrine disruptors, known as obesogens, have been directly linked to the obesity epidemic. Its etiology is generally associated with a sedentary lifestyle, a high-fat diet and genetic predisposition, but environmental factors, such as obesogens, have also been reported as contributors for this pathology. In brief, obesogens are exogenous chemical compounds that alter metabolic processes and/or energy balance and appetite, thus predisposing to weight gain. Although this theory is still recent, the number of compounds with suspected obesogenic activity has steadily increased over the years, though many of them remain a matter of debate. Technical-grade chlordane is an organochlorine pesticide widely present in the environment, albeit at low concentrations. Highly lipophilic compounds can be metabolized by humans and animals into more toxic and stable compounds that are stored in fat tissue and consequently pose a danger to the human body, including the physiology of adipose tissue, which plays an important role in weight regulation. In addition, technical-grade chlordane is classified as a persistent organic pollutant, a group of chemicals whose epidemiological studies are associated with metabolic disorders, including obesity. Herein, we discuss the emerging roles of obesogens as threats to public health. We particularly discuss the relevance of chlordane persistence in the environment and how its effects on human and animal health provide evidence for its role as an endocrine disruptor with possible obesogenic activity.